Bayer Intellectual Property Gmbh

Bayer Pharma Aktiengesellschaft

Aicuris Gmbh + Co. Kg.

Bayer Schering Pharma Ag

Bayer Healthcare Aktiengesellschaft

Aicuris Anti-infective Cures Gmbh

Aic246 Ag & Co. Kg

Mario Jeske

Jörg Keldenich

Kerstin Henninger

Friederike Stoll

Metin Akbaba

Tobias Wunberg

Johannes-Peter Stasch

Andreas Knorr

Karl-Heinz Schlemmer

Elisabeth Perzborn

Holger Zimmermann

Hartmut Beck

Dieter Lang

Rolf Grosser

Ingo Flamme

Judith Baumeister

Guy Hewlett

Susanne Nikolic

Rudolf Schohe-Loop

Joachim Schuhmacher

Thomas Lampe

Peter Nell

Peter Kolkhof

Kai Thede

Hanno Wild

Jens-Kerim Ergüden

Felix Oehme

Katja Zimmermann

Susanne Röhrig

Christoph Gerdes

Anja Buchmüller

Mark Jean Gnoth

Yolanda Cancho Grande

Kersten Matthias Gericke

Ulrich Betz

Dirk Heimbach

Eckhard Bender

Mark Meininghaus

Jürgen Reefschläger

Frank Suessmeier

Frank Süβmeier

Frank Süssmeier

Alexander Hillisch

Lars Bärfacker

Raimund Kast

Joerg Keldenich

Eva-Maria Becker

Gunter Karig

Dmitry Zubov

Ulrich Rester

Dirk Schneider

Tse-I Lin

Michael Gerisch

Georges Von Degenfeld

Martina Klein

Jens Ackerstaff

Britta Olenik

Chantal Fürstner

Gerald Kleymann

Birgit Keil

Thomas Krämer

Sabine Arndt

Martin-Holger Hinz

Juergen Reefschlaeger

Jens Pohlmann

Chantal Furstner

Thomas Kraemer

Jens-Kerim Ergueden

Lin Tse-I

Dimitry Zubov

Frank Süßmeier

The invention relates to substituted dihydroquinazolines and to processes for their preparation and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular for use as antiviral agents, in particular against cytomegalo viruses.

Substituted dihydroquinazolines

Salts of 1-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)-2,4-dioxo-3-[(1R)-4-(trifluoromethyl) -2,3-dihydro-1H-inden-1-yl]-1,2,3,4-tetrahydropyrimidine-5-carboxylic acid of the formula (I), in particular amino acid salts such as the lysine salt and alkali metal salts such as the sodium salt and the potassium salt, processes for their preparation, medicaments comprising them and their use for controlling diseases.

Salts

The present application relates to novel substituted dihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.

Substituted dihydropyrazolones for treating cardiovascular and hematological diseases

The invention relates to novel substituted piperidines, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of cardiovascular disorders and tumor disorders.

Substituted piperidines as Par-1 antagonists

The present application relates to novel substituted dipyridyldihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and hematological diseases and kidney diseases, and for promoting wound healing.

Substituted dipyridyl-dihydropyrazolones and use thereof

The present application relates to novel substituted dihydropyrazolone derivatives, processes for their preparation, their use for treatment and/or prophylaxis of diseases and their use for the preparation of medicaments for treatment and/or prophylaxis of diseases, in particular cardiovascular and haematological diseases and kidney diseases, and for promoting wound healing.

Substituted dihydropyrazolones and their use

Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitors

The invention relates to novel substituted piperidines, to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular diseases and tumour diseases.

Substituted piperidines

The invention relates to heterocyclyl-substituted dihydroquinazolines of formula (I), to processes for their preparation, to medicaments containing them, and to methods for the treatment and/or prophylaxis of diseases, in particular, for use as anti-viral agents, in particular, against cytomegaloviruses.

Heterocyclyl-substituted dihydroquinazolines and their use as antiviral agents

The present application relates to novel, cyclically substituted furopyrimidine derivatives, methods for their production, their use for the treatment and/or prophylaxis of diseases and their use for the production of medicinal products for the treatment and/or prophylaxis of diseases, in particular for the treatment and/or prophylaxis of cardiovascular diseases.

Cyclically substituted furopyrimidine derivatives and use thereof

Growing community of inventors

Solingen, Germany

Mario Jeske